The factors limiting the rather inefficient derivation of human embryonic stem cells (HESCs) are not fully understood. The aim of this study was to analyze the sex ratio in our 42 preimplantation genetic diagnosis (PGD)-HESC lines, in an attempt to verify its affect on the establishment of HESC lines. The ratio between male and female PGDderived cell lines was compared. We found a significant increase in female cell lines (76%). This finding was further confirmed by a meta-analysis for combining the results of all PGD-derived HESC lines published to date (148) and all normal karyotyped HESC lines derived from spare in vitro fertilization embryos worldwide (397). Further, gender determination of embryos demonstrated that this difference originates from the actual derivation process rather than from unequal representation of male and female embryos. It can therefore be concluded that the clearcut tendency for female preponderance is attributed to suboptimal culture conditions rather than from a true gender imbalance in embryos used for derivation of HESC lines. We propose a mechanism in which aberrant X chromosome inactivation and/or overexpression of critical metabolic X-linked genes might explain this sex dimorphism.
Introduction

D
isease-associated human pluripotent stem cell lines provide a powerful tool for studying a wide range of pathological conditions in humans, specifically those for which no good animal or cellular model systems are available [1] . In particular, these human embryonic stem cell (HESC) lines can be utilized to gain new insights on aberrant events that take place during early human embryo development, which are inaccessible for research. HESCs can also be used to explore new therapeutic protocols, including gene therapybased treatments and disease-oriented drug screening and discovery. For these reasons, much effort is invested in the establishment of new pluripotent HESC lines that carry mutations for a myriad of genetic conditions and serve as cellbased systems for basic and applied research.
One approach to obtain diseased pluripotent SC lines is to derive them directly from preimplantation diseased embryos [2, 3] that are frequently obtained from preimplantation genetic diagnosis (PGD) programs. PGD is performed on carrier couples who are at high risk of transmitting a genetic defect to their offspring and wish the birth of an unaffected baby. As PGD requires in vitro fertilization (IVF), the embryos are available for biopsy and genetic analysis at a very early stage, prior to implantation [4] [5] [6] [7] . Using various singlecell molecular diagnostic techniques, the embryos are tested for the genetic defect for which PGD is performed, and only disease-free embryos are transferred into the uterus for implantation. Affected embryos are usually discarded. They can, however, serve as a valuable source for the derivation of HESC lines carrying the naturally inherited mutations associated with particular disorders. The great advantage of this approach for establishing mutant HESC lines is that it is based on natural transmission of inherited disorders that have been characterized with an identified phenotype [1, 8, 9] . To date, derivation of HESC lines from genetically abnormal embryos has been reported by a number of groups, including ours, for the generation of cellular models for a variety of heritable conditions [2, 3, [10] [11] [12] .
An alternative approach for establishing mutant pluripotent SC lines is to generate patient-specific induced pluripotent stem (iPS) cells [13] [14] [15] [16] [17] . Although iPS cells are easier to obtain and may even complement HESCs under specific conditions, they still need to be compared with HESCs, which are still considered the gold standard by which all other pluripotent SCs are judged [18] [19] [20] . There are, however, factors that affect the establishment and maintenance of HESC lines that are not fully understood. Embryo gender was suggested as being one of them. The aims of this study were to analyze the sex ratio in our disease-bearing HESC lines and to attempt to identify the origins of sex discrepancy.
Materials and Methods
Donors
Couples undergoing PGD were asked to donate their affected embryos for SC derivation rather than have them discarded. The use of preimplantation genetically diagnosed affected embryos for HESC derivation was performed in compliance with protocols approved by the National Ethics Committee (7/04-043; 87/07) and the acceptance of a written informed consent. The couples' participation in the study was voluntary and there was no monetary compensation for their embryo donation.
Preimplantation genetic diagnosis
PGD was performed as previously described [4, 7] . Singlecell biopsies were molecularly analyzed by PCR or FISH analysis for the particular mutation carried by the parent(s). Based on the results of the genetic analysis, embryos unsuitable for reproductive needs were donated for HESC derivation and further cultured to the blastocyst stage.
HESC derivation protocol
Derivation was carried out using established protocols [21] . In short, the inner cell masses (ICMs) were isolated either by immunosurgery or mechanically, by laser-assisted micromanipulation ( Fig. 1) , or by manual cutting with an ultrasharp splitting blade (Bioniche). The intact ICM clumps were placed on a feeder cell layer of mitomycin C-inactivated treated mouse embryonic fibroblasts and cultured in HESC media (knockout DMEM supplemented with 20% KO-serum replacement, 1% nonessential amino acids, 1 mM l-glutamine, 0.5% insulin-transferrin-selenium, 50 U/mL penicillin, 50 mg/mL streptomycin, 0.1 mM beta-mercaptoethanol, and 30 ng/mL bFGF). Outgrowths of proliferating HESCs were manually propagated using the cut-and-paste method. Following 5-7 passages, the newly established cell lines were FIG. 1. Laser micromanipulation to isolate the inner cell mass (ICM) during derivation of human embryonic stem cells. A day-7 blastocyst diagnosed by preimplantation genetics as being affected is removed from the zona pellucida (ZP) using laser-assisted micromanipulation technology. The biopsy pipette is used to pull the blastocyst through the hole that was made in the ZP during embryo biopsy at day 3 postfertilization (A-F). A few laser shots of 980 ms (300 mW) were used to separate the ICM from the trophoblast cells at the opposite side of the blastocyst (G-I).
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further propagated by collagenase type IV and then frozen for future use.
Characterization of HESC lines
The newly established cell lines were characterized for self-renewal ability, expression of undifferentiated cell specific markers (Oct4, Rex1, Nanog, SOX2, alkaline phosphatase, Tra-1-60, and SSEA3), karyotype, and pluripotent potential by forming embryoid bodies in vitro or by teratoma induction in vivo. Established cell lines were then molecularly tested for the genetic defect that is carried by the couple to confirm their genotype using the same protocols applied for the one-cell PGD tests.
Gender determination
The gender of the preimplantation embryo was determined by molecular testing for the presence of the Y-linked Sry gene, in addition to the characterization of Amelogenein, Zfx, and several other X-linked polymorphic markers. The gender of the derived ES cell line was determined by analyzing genomic DNA extracted from the HESCs using the same PCR primers and reactions used for the PGD analysis.
Statistical analysis
The one-sample binomial test was used to test whether the proportion of females significantly deviated from the 50% expected. This test was performed for a sample size of > 6. Two-sample proportion tests were used to compare blastocyst development of female versus male embryos.
Results
In this report, we describe a list of disease-bearing HESC lines, which we established in the Shaare Zedek and Tel Aviv Sourasky Medical Centers. These HESC lines were all exclusively established from genetically affected embryos that were donated by couples undergoing PGD treatment (Table  1) . Our large collection includes 42 mutant HESCs lines with dominant (17 lines) and recessive (3 lines) conditions as well as X-linked disorders (20 lines) and chromosomal rearrangements (2 lines). Among those, to the best of our knowledge, is the largest collection of HESC lines associated with trinucleotide repeats expansion disorders, counting fragile X syndrome (9 lines), myotonic dystrophy type 1 (7 lines), and spinal and bulbar muscular atrophy X-linked (1 line). In addition, we have several lines that carry cancer predisposition mutations, such as retinoblastoma, familial adenomatous polyposis, and susceptibility to breast and ovarian cancer (BRCA1). Moreover, as we perform diagnosis of all possible conditions regardless of their prevalence in the general population, we have established cell lines for a wide range of diseases, some of which are extremely rare in the general population and are considered as private mutations, such as hypohidrotic ectodermal dysplasia, congenital insensitivity to pain with anhidrosis, branchiootorenal syndrome, as well as HESC lines that carry unbalanced translocations that are naturally embryonic lethal (t(12;11) and t(1;12)). We are currently employing these HESC lines for studying different aspects of human genetics, embryogenesis, and cell therapy [2] .
Examination of the sex distribution among our mutant HESC lines revealed that 76% of them were females (29 female vs. 9 male HESC lines; Table 1 ). This sex ratio is statistically different from the 50% (P < 0.01) that would be expected. This value is even more notable when taking into account the fact that more male ICMs were plated for HESC derivation than female ones (53% of all the blastocysts; data not shown).
After having obtained such a high ratio of females among our PGD-HESC lines, we performed a meta-analysis to integrate the results on gender distribution in all PGD-HESC lines published to date in scientific journals and publications from international HESC banks. The gender of all 148 PGDderived HESC lines was reported and the findings are summarized in Table 2 . Altogether, we found that 67% of PGD-derived HESC lines are female, significantly different from the 50% expected distribution (P = 0.0001) and confirming our data. As PGD-related cell lines are genetically abnormal, it is theoretically possible that male embryos are preferentially less viable because of distinct mutations, particularly in X-linked conditions. This is very unlikely, however, because the increase in the sex ratio of females observed among the mutant HESC lines persisted after excluding the cases of X-linked conditions, reaching a bias of up to 80% females (data not shown). In addition, the bias toward female gender was also evident among cell lines derived from embryos that had undergone biopsy for preimplantation genetic screening for chromosomal aberrations but were eventually found to be karyotypically normal [10] .
In contrast to PGD for sex selection in which only embryos with the desired gender are transferred, PGD for X-linked diseases enables determination of the gender of an embryo from the very early cleavage stage through the blastocyst stage and until birth. Therefore, we attempted to determine the origin of the sex bias toward females in our HESC lines by examining embryo gender prior to and following embryo biopsy (days 3 and 5 postfertilization, respectively). These data were obtained from PGD cycles for X-linked diseases (Table 3 ). There was no bias toward females in cleavagestage embryos (day 3 postfertilization), and the percentage of females was even lower than the 50% expected (45.9% females, 629/1370, P < 0.01). Moreover, the developmental potential toward the blastocyst stage was not statistically different between males and females (21.6% and 23.1%, respectively; P > 0.05, 2-sample proportion test). In addition, only 48.0% (96/200) of the babies born following PGD were females, which is not significantly different from the 51.3% females born following IVF-intracytoplasmic sperm injection (ICSI) in both medical centers (P > 0.05). Overall, we showed equal representation of males and females among embryos, both prior to and following embryo biopsy. This is in accordance with our PGD policy for X-linked diseases, in which both female carriers as well as affected males are considered unsuitable for transfer and therefore are equally available for HESC line derivation.
In light of the above findings, we hypothesized that the significant increase in XX female HESC lines is most likely attributed to culture conditions upon derivation rather than an a priori overrepresentation of female embryos available for manipulation. To test this hypothesis, we analyzed the sex ratio of all, to the best of our knowledge, wild-type HESC lines with normal karyotype thus far established from surplus IVF embryos. Such embryos are donated by infertile Ref. [21] . HESC, human embryonic stem cell; PGD, preimplantation genetic diagnosis.
couples undergoing IVF treatment, which resulted in the cryopreservation of their excess embryos. Gender type of all these 397 cell lines, derived in 35 different SC centers worldwide, was examined. Although when examining the sex ratio within each SC center separately, differences are not always apparent; a significant bias favoring female over male HESC lines is observed when accumulating all data (55.4%, P < 0.05; Table 4 ).
Discussion
In this study, we describe a unique set of disease-bearing PGD-derived HESC lines that can serve as new and improved models for studying various human pathologies. Our findings demonstrate a clear-cut propensity toward higher success in the derivation of female cell lines over male ones. In contrast to PGD for sex selection in which only embryos with the desired gender are transferred, PGD for X-linked diseases enables embryo gender determination from the very early cleavage stage through the blastocyst stage and prior to their manipulation for SC derivation. It therefore makes it possible to study the origin of this sex bias in the established HESC lines. Our results demonstrate that the source of the gender predisposition is the derivation process itself, rather than from unequal representation between male and female embryos at any stage during development. We support our findings by integrating them with the results of all SC centers worldwide who are engaged in the derivation of HESC lines following PGD analysis. To rule out any contribution of embryo biopsy as a cause for the sex bias among the established HESC lines, we performed a meta-analysis of the sex ratio of all wild-type [36] . Assisted reproduction technologies have been proposed to have a slight effect on the sex ratio of new born babies (1.5%-2.5%; reviewed in [37] ). It was suggested that there are more male blastocysts selected for embryo transfer, because they grow faster, but this cannot be proved when sex determination is retrospectively made following delivery. Our results determining the embryo gender prior to implantation in X-linked PGD cycles unequivocally show that no such sex bias exists among new born babies following assisted reproduction technologies.
In the clinical setting, there is a well-documented disproportionate loss of males following natural conception and at birth, reaching gender equilibrium by the third or fourth decade of life and followed by a further decline into old age. Previous studies on singleton pregnancies have found male fetuses (compared with females) to be an independent risk factor for adverse pregnancy outcome [38] . These results are in agreement with our findings on female HESC lines being more adaptive to the suboptimal culture conditions.
The question arises as to which mechanism might explain the more efficient derivation of female HESCs over males. It would appear that pluripotent XY cells are more vulnerable than pluripotent XX cells. As the major difference between the two genders is the presence of an additional X chromosome, it is tempting to suggest that a difference in the epigenetic state and activity of this extra chromosome may account for the preference of female ICM survival in vitro. The state of X chromosome inactivation has been shown to considerably vary among different WT-HESC lines [39, 40] because of suboptimal culture conditions, such as exposure to oxygen stress. This possibility is supported by the recent publication of Guenther et al., who concluded that uncontrolled laboratory-specific conditions may contribute to differential gene expression between pluripotent stem cell lines [41] . It is interesting to note that, in contrast to humans, the maintenance of stable XX ESC lines from mouse blastocysts is relatively difficult because of the frequent loss of one of the two active X chromosomes [42] . It has been also shown that DNA methylation is globally reduced in XX mouse ESC lines and that this may provide the basis for X-chromosome instability [42] . Using conventional methods for HESC derivation may not only induce precocious X inactivation, but also impose cellular stress, leading to proliferation of specific cells that are best adapted to the suboptimal growth conditions available. We herein suggest a possible mechanism by which aberrant X chromosome inactivation in female undifferentiated cells eventually favors XX HESC outgrowth and proliferation over their XY counterparts. A complementary explanation may be overexpression of genes critical for metabolism and survival under stress conditions, which are located on the X chromosome (eg, G6PD and HPRT) and are known to control key metabolic functions [43] . This may lead to the favoring of XX cell growth in suboptimal culture conditions, which do not exactly mimic the natural embryo environment and can expose cells to stressful conditions. Although we are unable to pinpoint the culture-associated factors that lead to this female propensity because of the lack of information regarding the methodologies and conditions that were used by the different centers at the time of derivation, our results highlight the importance of optimizing culture conditions at the time of derivation as well as during culture of HESCs. This is further supported by the recent publications related to epigenetic errors and genomic instabilities acquired during long-term culture of HESCs and derivation of iPS cells [44, 45] . Further work is warranted to reveal this yet unknown mechanism.
Conclusions
We here describe a gender dimorphism in the establishment and maintenance of HESC lines, resulting in the availability of more XX lines than XY lines. This may be due to the conventional culture conditions that provide a growth advantage to cells in which either two X chromosomes are expressed or, alternatively, demonstrate precocious X inactivation. Future investigations into the factors controlling derivation and proliferation of HESCs are warranted to elucidate the mechanism responsible for this phenomenon.
